Phase Ib Trial of Afatinib and BI 836845 in Advanced Non-Small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Park, Keunchil [1 ]
Lin, Chia-Chi [2 ]
Huang, Dennis Chin-Lun [3 ]
Shin, Heather Hye-Jung [4 ]
Bogenrieder, Thomas [5 ]
Tan, Daniel S. -W. [6 ]
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea
[2] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan
[3] Boehringer Ingelheim Taiwan Ltd, Taipei, Taiwan
[4] Boehringer Ingelheim Korea, Seoul, South Korea
[5] Boehringer Ingelheim Rcv, Vienna, Austria
[6] Natl Canc Ctr, Dept Med Oncol, Singapore, Singapore
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
Monoclonal antibody; IGF; Phase; 1; NSCLC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-100
引用
收藏
页码：S554 / S555
页数：2
相关论文
共 50 条
  • [1] Phase Ib trial of afatinib and BI 836845 in advanced non-small cell lung cancer (NSCLC)
    Tan, D.
    Lin, C. -C.
    Huang, D. Chin-Lun
    Jung, H.
    Bogenrieder, T.
    Park, K.
    ANNALS OF ONCOLOGY, 2015, 26 : 147 - 147
  • [2] Phase lb Trial of Afatinib and BI 836845 in Advanced NSCLC: Dose Escalation and Safety Results
    Park, Keunchil
    Cho, Byoung Chul
    Lee, Ki Hyeong
    Su, Wu-Chou
    Kim, Sang-We
    Lin, Chia-Chi
    Huang, Dennis Chin-Lun
    Jung, Helen Hayoun
    Geng, Yuan
    Tan, Daniel Shao Weng
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1187 - S1188
  • [3] Afatinib: A Review in Advanced Non-Small Cell Lung Cancer
    Keating, Gillian M.
    TARGETED ONCOLOGY, 2016, 11 (06) : 825 - 835
  • [4] Afatinib treatment in advanced non-small cell lung cancer
    Hurwitz, Jane L.
    Scullin, Paula
    Campbell, Lynn
    LUNG CANCER-TARGETS AND THERAPY, 2011, 2 : 47 - 57
  • [5] Afatinib: A Review in Advanced Non-Small Cell Lung Cancer
    Gillian M. Keating
    Targeted Oncology, 2016, 11 : 825 - 835
  • [6] Vinorelbine/gemcitabine in advanced non-small cell lung cancer (NSCLC):: a phase I trial
    Krajnik, G
    Wein, W
    Greil, R
    Marhold, F
    Mohn-Staudner, A
    Kummer, F
    Malayeri, R
    Zöchbauer-Müller, S
    Huber, H
    Pirker, R
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (12) : 1977 - 1980
  • [7] Gefitinib and Afatinib Treatment in an Advanced Non-small Cell Lung Cancer (NSCLC) Patient Undergoing Hemodialysis
    Bersanelli, Melissa
    Tiseo, Marcello
    Artioli, Fabrizio
    Lucchi, Leonardo
    Ardizzoni, Andrea
    ANTICANCER RESEARCH, 2014, 34 (06) : 3185 - 3188
  • [8] A phase II trial of weekly cisplatin and docetaxel in advanced non-small cell lung cancer (NSCLC)
    Sovak, M. A.
    Lutzker, S.
    Guensch, L.
    Joyce, M.
    Schwartz, S.
    Wu, Y.
    Zheng, L.
    Aisner, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] A phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC)
    Kim, Se Hyun
    Shim, Hyo Sup
    Cho, Jaeho
    Jeong, Jae Heon
    Kim, Sun Mi
    Hong, Yun Kyoung
    Sung, Ji Hee
    Ha, Sang-Jun
    Kim, Hye Ryun
    Chang, Hyun
    Kim, Joo Hang
    Tania, Crombet
    Cho, Byoung Chul
    LUNG CANCER, 2013, 79 (03) : 270 - 275
  • [10] A phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC).
    Kim, Han Sang
    Cho, Byoung Chul
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345